Clinical Trial

A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor

Name: A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor — clinical trial record (NCT07566247)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is an open-label, multicenter, dose-escalation and dose-expansion Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of AK150 in patients with advanced malignant solid tumors.

Trial Details

NCT Number	NCT07566247
Lead Sponsor	Akeso
Conditions	Advanced Malignant Solid Tumors
Enrollment	96 participants
Start Date	2026-04-30
Primary Completion	2029-02-21 (estimated)
Study Completion	2029-06-07 (estimated)
Updated on ClinicalTrials.gov	2026-05-05